Vitamin B12 is identified as the inhibitor of a key enzyme in hereditary Parkinson's disease

Thursday, April 4, 2019 - 13:02 in Health & Medicine

Parkinson's is the most common, chronic neurodegenerative movement disorder affecting 1% of the global population over seventy years of age. Right now, there is no cure for this disease and the available treatments focus on addressing its symptoms but not its progression.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net